PuSH - Publikationsserver des Helmholtz Zentrums München

48 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
1.
Senft, D. & Jeremias, I.: A rare subgroup of leukemia stem cells harbors relapse-inducing potential in acute lymphoblastic leukemia. Exp. Hematol. 69, 1-10 (2019)
2.
Enciso, N.* et al.: Mesenchymal stem cells: Migration towards target tissues. Exp. Hematol. 44, 1, S108-S108 (2016)
3.
Oezdemir, E. et al.: A rare subpopulation of dormant, drug resistant stem cells in all mimics cells of minimal residual disease. Exp. Hematol. 44, S94-S94 (2016)
4.
Vergalli, J. et al.: Novel genetically engineered patient-derived xenograft (GEPDX) models reveal that xiap plays an essential role for patients´all growing in mice. Exp. Hematol. 44, S105-S105 (2016)
5.
Saito, Y.* et al.: Development of human hemato-lymphoid system in human cytokine knock-in RAG2-/-IL2RG-/- mice engrafted with peripheral blood mobilized CD34+ cells. Exp. Hematol. 43, S92 (2015)
6.
Alves, C.C. ; Tiedt, S. & Jeremias, I.: Identification and isolation of a rare population of low-cycling, self-renewing and drug-resistant acute lymphoblastic leukemia xenograft cells. Exp. Hematol. 42, S28 (2014)
7.
Istvanffy, R.* et al.: Rapid upregulation of CTGF under stress conditions is required for HSC maintenance through cross-talk of canonical Wnt and AKT signaling. Exp. Hematol. 42, S40 (2014)
8.
Moignard, V.* et al.: Decoding the transcriptional program for blood development from whole tissue single-cell gene expression measurements. Exp. Hematol. 42, S52 (2014)
9.
Thalheimer, F.B.* et al.: Cytokine-regulated GADD45G induces differentiation and lineage selection in hematopoietic stem cells. Exp. Hematol. 42, S57 (2014)
10.
Polzer, H. ; Janke, H. ; Schmid, D. ; Hiddemann, W. & Spiekermann, K.: CBL mutants activate AKT to induce transformation in cooperation with class III receptor tyrosine kinases. Exp. Hematol. 41, 271-280 (2013)
11.
Polzer, H. ; Janke, H. ; Schmid, D. ; Hiddemann, W. & Spiekermann, K.: Casitas B-lineage lymphoma mutants activate AKT to induce transformation in cooperation with class III receptor tyrosine kinases. Exp. Hematol. 41, 271-280 (2013)
12.
Zorn, J. et al.: Tolerance in DLA-haploidentical canine littermates following CD6-depleted marrow transplantation and donor lymphocyte transfusion. Exp. Hematol. 37, 998-1006 (2009)
13.
Rawat, V.P.S. et al.: The transforming potential of Cdx2 is dependent on its serine108 in vivo and can be counteracted by MAPK inhibitors. Exp. Hematol. 36, S1-S2 (2008)
14.
Henning, K.* et al.: mNotch1 signaling and erythropoietin cooperate in erythroid differentiation of multipotent progenitor cells and upregulate beta-globin. Exp. Hematol. 35, 1321-1332 (2007)
15.
Mayr, C. et al.: MDM2 is recognized as a tumor-associated antigen in chronic lymphocytic leukemia by CD8+ autologous T lymphocytes. Exp. Hematol. 34, 44-53 (2006)
16.
McIvor, Z.* et al.: Transient expression of PU.1 commits multipotent progenitors to a myeloid fate whereas continued expression favors macrophage over granulocyte differentiation. Exp. Hematol. 31, 39-47 (2003)
17.
Wendtner, C.-M.* et al.: High level of transgene expression in primary chronic lymphocytic leukemia cells using helper-virus-free recombinant Epstein-Barr virus vectors. Exp. Hematol. 31, 99-108 (2003)
18.
Conrad, C.* ; Gottgens, B.* ; Kinston, S.* ; Ellwart, J. & Huss, R.*: GATA transcription in a small rhodamine 123lowCD34+subpopulation of a peripheral blood-derived CD34-CD105+ mesenchymal cell line. Exp. Hematol. 30, 887-895 (2002)
19.
Schleuning, M.* et al.: Hematopoitic stem cell transplantation after reduced-intensity conditioning as treatment of sickle cell disease. Exp. Hematol. 30, 7-10 (2002)
20.
Spiekermann, K. et al.: Constitutive activation of STAT3 and STAT5 is induced by leukemic fusion proteins with protein tyrosine kinase activity and is sufficient for transformation of hematopoitic precursor cells. Exp. Hematol. 30, 262-271 (2002)